CN Stock MarketDetailed Quotes

000952 Hubei Guangji Pharmaceutical

Watchlist
  • 6.19
  • -0.16-2.52%
Market Closed Nov 15 15:00 CST
2.17BMarket Cap-9336P/E (TTM)

Hubei Guangji Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-11.54%462.19M
-13.80%296.46M
56.27%180.16M
-7.50%737.82M
-2.57%522.49M
-8.54%343.91M
-13.49%115.29M
1.54%797.64M
12.59%536.28M
16.30%376.02M
Operating revenue
-11.54%462.19M
-13.80%296.46M
56.27%180.16M
-7.50%737.82M
-2.57%522.49M
-8.54%343.91M
-13.49%115.29M
1.54%797.64M
12.59%536.28M
16.30%376.02M
Other operating revenue
----
71.09%7.47M
----
176.27%7.71M
----
2,850.02%4.37M
----
494.89%2.79M
----
-82.77%147.98K
Total operating cost
6.24%628.44M
9.95%404.57M
49.09%239.27M
15.00%862.66M
11.88%591.55M
2.42%367.96M
19.43%160.48M
6.34%750.16M
26.16%528.71M
26.37%359.25M
Operating cost
-4.30%355.86M
-6.68%222.07M
59.92%150.66M
6.58%535.62M
6.19%371.86M
-5.46%237.97M
4.36%94.21M
3.76%502.53M
24.92%350.19M
24.87%251.71M
Operating tax surcharges
1.33%10.07M
-2.72%6.69M
-13.02%3.54M
1.39%13.69M
0.14%9.94M
1.16%6.87M
18.84%4.07M
-15.45%13.5M
-16.66%9.93M
-18.35%6.79M
Operating expense
-2.20%28.39M
-13.08%19.41M
6.88%10.44M
15.03%38.64M
24.84%29.03M
37.71%22.33M
106.17%9.76M
10.87%33.59M
49.22%23.25M
72.96%16.21M
Administration expense
44.13%150.5M
66.78%103.07M
62.31%50.22M
34.24%156.19M
21.67%104.42M
25.02%61.8M
40.02%30.94M
8.74%116.35M
20.10%85.82M
23.52%49.43M
Financial expense
42.22%38.91M
110.27%24.91M
64.06%8.32M
187.73%43.77M
244.53%27.36M
104.81%11.85M
8.67%5.07M
-3.64%15.21M
-26.67%7.94M
-9.86%5.79M
-Interest expense (Financial expense)
38.06%44.08M
90.48%29.15M
68.45%9.34M
132.93%49.15M
124.88%31.93M
62.52%15.31M
16.67%5.54M
26.29%21.1M
21.75%14.2M
38.15%9.42M
-Interest Income (Financial expense)
32.67%-1.65M
30.76%-1.05M
-11.52%-613.08K
-72.70%-3.46M
-78.39%-2.45M
-60.43%-1.51M
-29.12%-549.77K
37.90%-2M
39.05%-1.37M
27.11%-943.52K
Research and development
-8.65%44.7M
4.73%28.42M
-2.05%16.1M
8.37%74.75M
-5.11%48.94M
-7.45%27.14M
78.90%16.43M
32.49%68.98M
77.99%51.57M
57.76%29.32M
Credit Impairment Loss
111.76%392K
84.70%-618.03K
-352.74%-1.25M
99.38%-27.48K
27.34%-3.33M
-25.44%-4.04M
243.16%492.63K
-327.64%-4.45M
-206.87%-4.59M
-167.05%-3.22M
Asset Impairment Loss
-737.73%-14.76M
-570.96%-12.61M
-190.29%-741.26K
-85.55%-14.26M
254.61%2.32M
310.08%2.68M
139.65%821.01K
-148.47%-7.69M
114.11%652.85K
123.72%652.85K
Other net revenue
2.24%-4.27M
-101.12%-7.94M
2,863.21%2.92M
-221.95%-16.22M
-140.99%-4.37M
-138.51%-3.95M
-101.08%-105.76K
-65.06%13.3M
-57.90%10.65M
-62.03%10.26M
Invest income
47.87%-3.64M
42.59%-2.92M
71.36%-855.48K
-259.03%-10.02M
-241.43%-6.99M
-209.47%-5.09M
-150.83%-2.99M
-66.34%6.3M
-73.72%4.94M
-75.50%4.65M
-Including: Investment income associates
69.70%-2.12M
70.83%-1.49M
71.36%-855.48K
-305.89%-8.93M
-266.08%-6.99M
-215.80%-5.09M
-147.99%-2.99M
-74.71%4.34M
-75.93%4.21M
-75.64%4.4M
Asset deal income
----
----
--84.38K
105.88%253.34K
----
----
--0
-891.92%-4.31M
----
----
Other revenue
277.32%13.75M
227.22%8.21M
262.32%5.68M
-66.52%7.85M
-62.23%3.64M
-69.30%2.51M
-75.44%1.57M
17.55%23.43M
41.33%9.65M
36.90%8.17M
Operating profit
-132.26%-170.52M
-314.56%-116.06M
-24.04%-56.19M
-332.07%-141.05M
-502.90%-73.42M
-203.61%-28M
-618.97%-45.3M
-48.58%60.78M
-77.92%18.22M
-59.08%27.02M
Add:Non operating Income
20.68%1.11M
8,019.56%1.06M
350,685.78%1.07M
33.21%1.2M
1.99%916.89K
-97.15%13.06K
-99.85%306
-86.20%899.42K
-6.89%898.98K
9,059.77%457.99K
Less:Non operating expense
121.48%1.59M
-96.02%25.68K
-82.38%91.67K
-49.22%811.45K
-50.85%717.04K
-48.23%645.47K
-57.59%520.16K
322.34%1.6M
460.81%1.46M
2,798.16%1.25M
Total profit
-133.55%-171M
-301.79%-115.02M
-20.49%-55.2M
-334.12%-140.67M
-514.53%-73.22M
-209.14%-28.63M
-694.28%-45.82M
-51.68%60.08M
-78.78%17.66M
-60.25%26.23M
Less:Income tax cost
202.36%1.46M
207.72%540.49K
-27.45%-535.01K
-5.25%11.75M
-133.40%-1.42M
-116.76%-501.75K
-872.81%-419.79K
-33.09%12.4M
-104.89%-610.16K
-63.19%2.99M
Net profit
FPtoL-172.46M
FPtoL-115.56M
FPtoL-54.67M
SL-152.41M
SL-71.79M
SL-28.13M
SL-45.4M
-54.93%47.68M
-74.18%18.27M
-59.84%23.24M
Net profit from continuing operation
-140.21%-172.46M
-310.88%-115.56M
-20.42%-54.67M
-419.63%-152.41M
-492.90%-71.79M
-221.04%-28.13M
-693.01%-45.4M
-54.93%47.68M
-74.18%18.27M
-59.84%23.24M
Less:Minority Profit
-188.11%-13.88M
-284.21%-8.92M
-206.02%-4.16M
-359.16%-12.17M
-194.82%-4.82M
-59.13%-2.32M
-94.09%-1.36M
38.37%-2.65M
52.23%-1.63M
21.73%-1.46M
Net profit of parent company owners
-136.76%-158.58M
-313.28%-106.65M
-14.69%-50.51M
-378.64%-140.25M
-436.44%-66.98M
-204.49%-25.8M
-627.02%-44.04M
-54.29%50.33M
-73.16%19.91M
-58.65%24.7M
Earning per share
Basic earning per share
-137.74%-0.4498
-313.44%-0.3014
-14.71%-0.1427
-376.48%-0.3962
-435.46%-0.1892
-203.70%-0.0729
-611.93%-0.1244
-55.23%0.1433
-73.84%0.0564
-59.50%0.0703
Diluted earning per share
-137.74%-0.4498
-313.44%-0.3014
-14.71%-0.1427
-376.24%-0.3942
-427.90%-0.1892
-201.82%-0.0729
-624.89%-0.1244
-55.42%0.1427
-73.24%0.0577
-58.76%0.0716
Other composite income
-125.70%-1.59K
-125.92%-4.5K
-265.79%-4.54K
116.26%13.97K
154.63%6.19K
263.92%17.36K
136.05%2.74K
111.95%6.46K
67.18%-11.33K
52.85%-10.59K
Other composite income of parent company owners
-125.70%-1.59K
-125.92%-4.5K
-265.79%-4.54K
116.26%13.97K
154.63%6.19K
263.92%17.36K
136.05%2.74K
111.95%6.46K
67.18%-11.33K
52.85%-10.59K
Total composite income
-140.23%-172.46M
-311.15%-115.57M
-20.44%-54.67M
-419.56%-152.4M
-493.11%-71.79M
-221.02%-28.11M
-693.56%-45.4M
-54.90%47.69M
-74.18%18.26M
-59.84%23.23M
Total composite income of parent company owners
-136.79%-158.58M
-313.58%-106.65M
-14.71%-50.51M
-378.57%-140.23M
-436.60%-66.97M
-204.46%-25.79M
-627.46%-44.04M
-54.26%50.34M
-73.17%19.9M
-58.65%24.69M
Total composite income of minority owners
-188.11%-13.88M
-284.21%-8.92M
-206.02%-4.16M
-359.16%-12.17M
-194.82%-4.82M
-59.13%-2.32M
-94.09%-1.36M
38.37%-2.65M
52.23%-1.63M
21.73%-1.46M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -11.54%462.19M-13.80%296.46M56.27%180.16M-7.50%737.82M-2.57%522.49M-8.54%343.91M-13.49%115.29M1.54%797.64M12.59%536.28M16.30%376.02M
Operating revenue -11.54%462.19M-13.80%296.46M56.27%180.16M-7.50%737.82M-2.57%522.49M-8.54%343.91M-13.49%115.29M1.54%797.64M12.59%536.28M16.30%376.02M
Other operating revenue ----71.09%7.47M----176.27%7.71M----2,850.02%4.37M----494.89%2.79M-----82.77%147.98K
Total operating cost 6.24%628.44M9.95%404.57M49.09%239.27M15.00%862.66M11.88%591.55M2.42%367.96M19.43%160.48M6.34%750.16M26.16%528.71M26.37%359.25M
Operating cost -4.30%355.86M-6.68%222.07M59.92%150.66M6.58%535.62M6.19%371.86M-5.46%237.97M4.36%94.21M3.76%502.53M24.92%350.19M24.87%251.71M
Operating tax surcharges 1.33%10.07M-2.72%6.69M-13.02%3.54M1.39%13.69M0.14%9.94M1.16%6.87M18.84%4.07M-15.45%13.5M-16.66%9.93M-18.35%6.79M
Operating expense -2.20%28.39M-13.08%19.41M6.88%10.44M15.03%38.64M24.84%29.03M37.71%22.33M106.17%9.76M10.87%33.59M49.22%23.25M72.96%16.21M
Administration expense 44.13%150.5M66.78%103.07M62.31%50.22M34.24%156.19M21.67%104.42M25.02%61.8M40.02%30.94M8.74%116.35M20.10%85.82M23.52%49.43M
Financial expense 42.22%38.91M110.27%24.91M64.06%8.32M187.73%43.77M244.53%27.36M104.81%11.85M8.67%5.07M-3.64%15.21M-26.67%7.94M-9.86%5.79M
-Interest expense (Financial expense) 38.06%44.08M90.48%29.15M68.45%9.34M132.93%49.15M124.88%31.93M62.52%15.31M16.67%5.54M26.29%21.1M21.75%14.2M38.15%9.42M
-Interest Income (Financial expense) 32.67%-1.65M30.76%-1.05M-11.52%-613.08K-72.70%-3.46M-78.39%-2.45M-60.43%-1.51M-29.12%-549.77K37.90%-2M39.05%-1.37M27.11%-943.52K
Research and development -8.65%44.7M4.73%28.42M-2.05%16.1M8.37%74.75M-5.11%48.94M-7.45%27.14M78.90%16.43M32.49%68.98M77.99%51.57M57.76%29.32M
Credit Impairment Loss 111.76%392K84.70%-618.03K-352.74%-1.25M99.38%-27.48K27.34%-3.33M-25.44%-4.04M243.16%492.63K-327.64%-4.45M-206.87%-4.59M-167.05%-3.22M
Asset Impairment Loss -737.73%-14.76M-570.96%-12.61M-190.29%-741.26K-85.55%-14.26M254.61%2.32M310.08%2.68M139.65%821.01K-148.47%-7.69M114.11%652.85K123.72%652.85K
Other net revenue 2.24%-4.27M-101.12%-7.94M2,863.21%2.92M-221.95%-16.22M-140.99%-4.37M-138.51%-3.95M-101.08%-105.76K-65.06%13.3M-57.90%10.65M-62.03%10.26M
Invest income 47.87%-3.64M42.59%-2.92M71.36%-855.48K-259.03%-10.02M-241.43%-6.99M-209.47%-5.09M-150.83%-2.99M-66.34%6.3M-73.72%4.94M-75.50%4.65M
-Including: Investment income associates 69.70%-2.12M70.83%-1.49M71.36%-855.48K-305.89%-8.93M-266.08%-6.99M-215.80%-5.09M-147.99%-2.99M-74.71%4.34M-75.93%4.21M-75.64%4.4M
Asset deal income ----------84.38K105.88%253.34K----------0-891.92%-4.31M--------
Other revenue 277.32%13.75M227.22%8.21M262.32%5.68M-66.52%7.85M-62.23%3.64M-69.30%2.51M-75.44%1.57M17.55%23.43M41.33%9.65M36.90%8.17M
Operating profit -132.26%-170.52M-314.56%-116.06M-24.04%-56.19M-332.07%-141.05M-502.90%-73.42M-203.61%-28M-618.97%-45.3M-48.58%60.78M-77.92%18.22M-59.08%27.02M
Add:Non operating Income 20.68%1.11M8,019.56%1.06M350,685.78%1.07M33.21%1.2M1.99%916.89K-97.15%13.06K-99.85%306-86.20%899.42K-6.89%898.98K9,059.77%457.99K
Less:Non operating expense 121.48%1.59M-96.02%25.68K-82.38%91.67K-49.22%811.45K-50.85%717.04K-48.23%645.47K-57.59%520.16K322.34%1.6M460.81%1.46M2,798.16%1.25M
Total profit -133.55%-171M-301.79%-115.02M-20.49%-55.2M-334.12%-140.67M-514.53%-73.22M-209.14%-28.63M-694.28%-45.82M-51.68%60.08M-78.78%17.66M-60.25%26.23M
Less:Income tax cost 202.36%1.46M207.72%540.49K-27.45%-535.01K-5.25%11.75M-133.40%-1.42M-116.76%-501.75K-872.81%-419.79K-33.09%12.4M-104.89%-610.16K-63.19%2.99M
Net profit FPtoL-172.46MFPtoL-115.56MFPtoL-54.67MSL-152.41MSL-71.79MSL-28.13MSL-45.4M-54.93%47.68M-74.18%18.27M-59.84%23.24M
Net profit from continuing operation -140.21%-172.46M-310.88%-115.56M-20.42%-54.67M-419.63%-152.41M-492.90%-71.79M-221.04%-28.13M-693.01%-45.4M-54.93%47.68M-74.18%18.27M-59.84%23.24M
Less:Minority Profit -188.11%-13.88M-284.21%-8.92M-206.02%-4.16M-359.16%-12.17M-194.82%-4.82M-59.13%-2.32M-94.09%-1.36M38.37%-2.65M52.23%-1.63M21.73%-1.46M
Net profit of parent company owners -136.76%-158.58M-313.28%-106.65M-14.69%-50.51M-378.64%-140.25M-436.44%-66.98M-204.49%-25.8M-627.02%-44.04M-54.29%50.33M-73.16%19.91M-58.65%24.7M
Earning per share
Basic earning per share -137.74%-0.4498-313.44%-0.3014-14.71%-0.1427-376.48%-0.3962-435.46%-0.1892-203.70%-0.0729-611.93%-0.1244-55.23%0.1433-73.84%0.0564-59.50%0.0703
Diluted earning per share -137.74%-0.4498-313.44%-0.3014-14.71%-0.1427-376.24%-0.3942-427.90%-0.1892-201.82%-0.0729-624.89%-0.1244-55.42%0.1427-73.24%0.0577-58.76%0.0716
Other composite income -125.70%-1.59K-125.92%-4.5K-265.79%-4.54K116.26%13.97K154.63%6.19K263.92%17.36K136.05%2.74K111.95%6.46K67.18%-11.33K52.85%-10.59K
Other composite income of parent company owners -125.70%-1.59K-125.92%-4.5K-265.79%-4.54K116.26%13.97K154.63%6.19K263.92%17.36K136.05%2.74K111.95%6.46K67.18%-11.33K52.85%-10.59K
Total composite income -140.23%-172.46M-311.15%-115.57M-20.44%-54.67M-419.56%-152.4M-493.11%-71.79M-221.02%-28.11M-693.56%-45.4M-54.90%47.69M-74.18%18.26M-59.84%23.23M
Total composite income of parent company owners -136.79%-158.58M-313.58%-106.65M-14.71%-50.51M-378.57%-140.23M-436.60%-66.97M-204.46%-25.79M-627.46%-44.04M-54.26%50.34M-73.17%19.9M-58.65%24.69M
Total composite income of minority owners -188.11%-13.88M-284.21%-8.92M-206.02%-4.16M-359.16%-12.17M-194.82%-4.82M-59.13%-2.32M-94.09%-1.36M38.37%-2.65M52.23%-1.63M21.73%-1.46M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data